Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an electrochemical DNA-based biosensor for the detection of the cardiovascular pharmacogenetic-altering SNP CYP2C9*3.

Talanta - 1 Nov 2023

Morais Stephanie L, Magalhães Júlia M C S, Domingues Valentina F, Delerue-Matos Cristina, Ramos-Jesus Joilson, Ferreira-Fernandes Hygor, Pinto Giovanny R, Santos Marlene, Barroso M Fátima

Abstract excerpt

Cardiovascular diseases are among the major causes of mortality and morbidity. Warfarin is often prescribed for these disorders, an anticoagulant with inter and intra-dosage variability dose required to achieve the target international normalized ratio. Warfarin presents a narrow therapeutic index, and due to its variability, it can often be associated with the risk of hemorrhage, or in other patients,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biosensing Techniques

Share to Cytochrome P-450 CYP2C9

Share to DNA Probes

Share to Pharmacogenetics

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 37276677
DOI: 10.1016/j.talanta.2023.124692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an electrochemical DNA-based biosensor for the detection of the cardiovascular pharmacogenetic-altering SNP CYP2C9*3.PMID 37276677Read ↗

DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation.Semantic proximity Read ↗

Electrochemical DNA sensor for detection of single nucleotide polymorphisms.Semantic proximity Read ↗

Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chips.Semantic proximity Read ↗

Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.Semantic proximity Read ↗

Visual genotyping of SNPs of drug-metabolizing enzymes by tetra-primer PCR coupled with a dry-reagent DNA biosensor.Semantic proximity Read ↗

A fully integrated and automated microsystem for rapid pharmacogenetic typing of multiple warfarin-related single-nucleotide polymorphisms.Semantic proximity Read ↗

Dry-reagent disposable biosensor for visual genotyping of single nucleotide polymorphisms by oligonucleotide ligation reaction: application to pharmacogenetic analysis.Semantic proximity Read ↗

Protein engineering of human cytochromes P450 and their allelic variants for nanobiotechnological applicationsSemantic proximity Read ↗

Electrochemical DNA biosensor using a disposable electrochemical printed (DEP) chip for the detection of SNPs from unpurified PCR amplicons.Semantic proximity Read ↗

Real-time and label-free detection of VKORC1 genes based on a magnetoelastic biosensor for warfarin therapy.Semantic proximity Read ↗

Disposable sensors for rapid screening of mutated genes.Semantic proximity Read ↗

Genotyping with a dried blood spot method: a useful technique for application in pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.